Biogeneric/biosimilar: Bill H.R. 1427 introduced

A group of lawmakers like Henry A. Waxman, Frank Pallone, Nathan Deal, and Jo Ann Emerson introduced H.R. 1427, the “Promoting Innovation and Access to Life-Saving Medicine Act,” a bipartisan bill to allow the United States Food and Drug Administration (USFDA) to approve affordable copies of biotech drugs. Biotech drugs, while often life-saving, are the fastest growing and most expensive components of the US’s prescription drug bill. Many of them cost tens of thousands of dollars a year — prices that put them out of reach of patients and impose an unsustainable burden on employers, insurers, and the federal government.
Link to press release Here
Link to proposed bill Here
Link to important highlights of bill Here